Literature DB >> 9564162

[1997 gastroenterology update--II].

W Fischbach1, V Gross, J Schölmerich, C Ell, P Layer, W E Fleig.   

Abstract

Mesh：

Year:  1998        PMID： 9564162     DOI： 10.1007/BF03044832

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN： 0723-5003


× No keyword cloud information.
  196 in total

1.  Epinephrine or epinephrine plus alcohol for injection of bleeding ulcers: a prospective randomized trial.

Authors:  S C Chung; H T Leong; A C Chan; J Y Lau; M Y Yung; J W Leung; A K Li
Journal:  Gastrointest Endosc       Date:  1996-06       Impact factor: 9.427

2.  Memory metal stents for palliation of malignant obstruction of the oesophagus and cardia.

Authors:  A May; M Selmaier; J Hochberger; L Gossner; S Mühldorfer; E G Hahn; C Ell
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

3.  Randomised study of endoscopic biliary endoprosthesis versus duct clearance for bileduct stones in high-risk patients.

Authors:  K B Chopra; R A Peters; P A O'Toole; S G Williams; A E Gimson; M G Lombard; D Westaby
Journal:  Lancet       Date:  1996-09-21       Impact factor: 79.321

4.  Metal stents for palliation of rectal carcinoma: a preliminary report on 12 patients.

Authors:  J F Rey; T Romanczyk; M Greff
Journal:  Endoscopy       Date:  1995-09       Impact factor: 10.093

5.  Fecal elastase test: evaluation of a new noninvasive pancreatic function test.

Authors:  J E Domínguez-Muñoz; C Hieronymus; T Sauerbruch; P Malfertheiner
Journal:  Am J Gastroenterol       Date:  1995-10       Impact factor: 10.864

6.  Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.

Authors:  K Oho; T Iwao; M Sumino; A Toyonaga; K Tanikawa
Journal:  Endoscopy       Date:  1995-06       Impact factor: 10.093

7.  Gianturco-Z stents in the palliative treatment of malignant esophageal obstruction and esophagotracheal fistulas.

Authors:  C Ell; A May; E G Hahn
Journal:  Endoscopy       Date:  1995-09       Impact factor: 10.093

8.  A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group.

Authors:  T Poynard; P Bedossa; M Chevallier; P Mathurin; C Lemonnier; C Trepo; P Couzigou; J L Payen; M Sajus; J M Costa
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

9.  Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

Authors:  S K Roberts; T M Therneau; A J Czaja
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

10.  Epidemiology of hepatitis D virus infection: changes in the last 14 years.

Authors:  C A Navascués; M Rodríguez; N G Sotorrío; P Sala; A Linares; A Suárez; L Rodrigo
Journal:  Am J Gastroenterol       Date:  1995-11       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.